National Cervical Screening Program monitoring report 2025

Web report

Last updated: 17 Nov 2025

Topic: Cancer screening

AIHW (Australian Institute of Health and Welfare) (2025) National Cervical Screening Program monitoring report 2025, AIHW, Australian Government, accessed 24 June 2026.

PDF | 10.4MB

Save web report

Latest edition

A10 Adherence to recommendation for follow-up

Table A10.1: Time to follow-up HPV test after intermediate risk screening episode, participants aged 25–74, 2023
Time to follow-up HPV test (months)	Number who had follow-up HPV test	Cumulative number who had follow-up HPV test	Per cent of intermediate risk participants who had follow-up HPV test (%)	Cumulative per cent of intermediate risk participants who had follow-up HPV test (%)
1	32	32	0.1	0.1
2	26	58	0.1	0.1
3	34	92	0.1	0.2
4	42	134	0.1	0.3
5	69	203	0.2	0.5
6	102	305	0.2	0.7
7	142	447	0.3	1.0
8	129	576	0.3	1.3
9	216	792	0.5	1.8
10	2,346	3,138	5.4	7.2
11	4,332	7,470	10.0	17.2
12	5,657	13,127	13.0	30.2
13	8,130	21,257	18.7	48.9
14	4,057	25,314	9.3	58.2
15	2,425	27,739	5.6	63.8
16	1,718	29,457	4.0	67.7
17	2,054	31,511	4.7	72.5
18	1,252	32,763	2.9	75.3
19	726	33,489	1.7	77.0
20	813	34,302	1.9	78.9
21	490	34,792	1.1	80.0
>21	1,053	35,845	2.4	82.4
No follow-up HPV test	7,642	43,487	17.6	100.0

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.2: Adherence to recommendation for follow-up after intermediate risk screening episode, by age, 2023
Age group	Number who had follow-up HPV test 9–15 months after screening episode	Adherence to recommendation for follow-up (%)
25–29	8,899	57.3
30–34	4,028	57.2
35–39	3,033	61.6
40–44	2,561	64.5
45–49	2,170	66.3
50–54	1,966	67.4
55–59	1,600	69.3
60–64	1,478	75.6
65–69	1,135	76.4
70–74	42	62.7
25–74	26,912	61.9

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.3: Adherence to recommendation for follow-up after intermediate risk screening episode, by state and territory, participants aged 25–74, 2023
State and territory	Number who had follow-up HPV test 9–15 months after screening episode	Adherence to recommendation for follow-up (%)
NSW	8,162	60.8
Vic	7,343	63.1
Qld	5,604	60.5
WA	2,911	62.5
SA	1,676	65.8
Tas	474	65.3
ACT	511	65.3
NT	227	54.7
Australia	26,912	61.9

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.4: Adherence to recommendation for follow-up after intermediate risk screening episode, by year, participants aged 25–74, 2018 to 2023
Year	Number who had follow-up HPV test 9–15 months after screening episode	Adherence to recommendation for follow-up (%)
2018	55,215	59.3
2019	52,663	59.0
2020	26,216	54.4
2021	20,069	50.9
2022	18,533	55.4
2023	26,912	61.9

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.5: Time to follow-up HPV test after intermediate risk follow-up episode, participants aged 25–74, 2023
Time to follow-up HPV test (months)	Number who had follow-up HPV test	Cumulative number who had follow-up HPV test	Per cent of intermediate risk participants who had follow-up HPV test (%)	Cumulative per cent of intermediate risk participants who had follow-up HPV test (%)
1	n.p.	n.p.	n.p.	n.p.
2	n.p.	n.p.	n.p.	n.p.
3	n.p.	n.p.	n.p.	n.p.
4	n.p.	n.p.	n.p.	n.p.
5	6	8	0.6	0.8
6	n.p.	n.p.	n.p.	n.p.
7	6	18	0.6	1.7
8	7	25	0.7	2.4
9	10	35	0.9	3.3
10	69	104	6.5	9.8
11	125	229	11.8	21.6
12	170	399	16.0	37.6
13	207	606	19.5	57.1
14	103	709	9.7	66.8
15	80	789	7.5	74.4
16	41	830	3.9	78.2
17	34	864	3.2	81.4
18	25	889	2.4	83.8
19	30	919	2.8	86.6
20	19	938	1.8	88.4
21	n.p.	n.p.	n.p.	n.p.
>21	27	969	2.5	91.3
No follow-up HPV test	92	1,061	8.7	100.0

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.6: Adherence to recommendation for follow-up after intermediate risk follow-up episode, by age, 2023
Age group	Number who had follow-up HPV test 9–15 months after follow-up episode	Adherence to recommendation for follow-up (%)
25–29	170	66.9
30–34	204	71.3
35–39	146	65.5
40–44	127	77.9
45–49	109	80.7
50–54	. .	. .
55–59	. .	. .
60–64	. .	. .
65–69	. .	. .
70–74	. .	. .
25–74	756	71.3

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.7: Adherence to recommendation for follow-up after intermediate risk follow-up episode by state and territory, participants aged 25–74, 2023
State and territory	Number who had follow-up HPV test 9–15 months after follow-up episode	Adherence to recommendation for follow-up (%)
NSW	184	71.3
Vic	249	72.8
Qld	165	68.2
WA	81	71.7
SA	46	71.9
Tas	7	77.8
ACT	12	70.6
NT	12	75.0
Australia	756	71.3

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A10.8: Adherence to recommendation for follow-up after intermediate risk follow-up episode, by year, participants aged 25–74, 2021 to 2023
Year	Number who had follow-up HPV test 9–15 months after screening episode	Adherence to recommendation for follow-up (%)
2021	3,232	60.3
2022	1,177	62.7
2023	756	71.3

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

This website needs JavaScript enabled in order to work correctly; currently it looks like it is disabled.
Please enable JavaScript to use this website as intended.